HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.

Abstract
The efficacy of autologous bone marrow transplantation in leukemia and lymphoma may depend upon the selective elimination of malignant cells from human bone marrow in vivo and in vitro. A cyclophosphamide derivative (ASTA-Z 7654) and etoposide (VP16-213) have been tested on lymphoma and leukemia cell lines in a model that may represent a bone marrow situation in complete remission. The influence of different concentrations of normal mononuclear cells and tumor cells in this model and the activity of the two chemotherapeutic agents in the presence of bone marrow cells or peripheral blood cells were evaluated. A major inhibitory effect was observed using the two agents in combination; low doses of ASTA-Z and VP16 consecutively added to the mixture of malignant cells and normal mononuclear cells resulted in a greater elimination of tumor line cells than with ASTA-Z alone at the current 100 micrograms/ml dose. In contrast, no major toxicity on normal human bone marrow precursors was observed; the effect of treatment on hemopoietic recovery with the two agents either alone or in combination was evaluated on CFU-GM growth after long-term bone marrow cultures. Despite a profound growth inhibition at day 0, a recovery was observed in all cases after 7 or 14 days. The use of multiple chemotherapeutic agents in the treatment of bone marrow in vitro could decrease the possibility of malignant cells surviving while sparing normal bone marrow precursors.
AuthorsP De Fabritiis, A Pulsoni, A Sandrelli, F Simone, S Amadori, G Meloni, F Mandelli
JournalBone marrow transplantation (Bone Marrow Transplant) Vol. 2 Issue 3 Pg. 287-98 (Oct 1987) ISSN: 0268-3369 [Print] England
PMID3502785 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Etoposide
  • Cyclophosphamide
  • mafosfamide-lysine
Topics
  • Bone Marrow (drug effects)
  • Bone Marrow Cells
  • Cell Survival (drug effects)
  • Cells, Cultured
  • Colony-Forming Units Assay
  • Cyclophosphamide (administration & dosage, analogs & derivatives)
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Etoposide (administration & dosage)
  • Hematopoietic Stem Cells (drug effects)
  • Humans
  • In Vitro Techniques
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: